Migraine Clinical Trials in New York, New York
13 recruitingNew York, New York
Showing 1–13 of 13 trials
Recruiting
Phase 3
A Clinical Trial to Evaluate Efficacy and Safety of Xeomin® Injections for Preventing Episodic Migraine
Episodic Migraine
Merz Therapeutics GmbH990 enrolled106 locationsNCT07018700
Recruiting
Phase 3
A Clinical Trial to Evaluate Efficacy and Safety of Xeomin® Injections for Preventing Chronic Migraine
Chronic Migraine
Merz Therapeutics GmbH780 enrolled106 locationsNCT07018713
Recruiting
Phase 3
Long-term Safety Study of Rimegepant in Pediatric Subjects for the Acute Treatment of Migraine
Acute Treatment of Migraine
Pfizer600 enrolled126 locationsNCT04743141
Recruiting
Phase 3
Randomized Study in Children and Adolescents With Migraine: Acute Treatment
Pediatric Migraine
Pfizer2,100 enrolled246 locationsNCT04649242
Recruiting
Not Applicable
MMA Embolization for Refractory Chronic Migraine
Migraine
Cerenovus, Part of DePuy Synthes Products, Inc.70 enrolled9 locationsNCT06735833
Recruiting
Phase 3
A Study to Assess the Adverse Events and Change in Disease Activity of Oral Atogepant Tablets in Pediatric Participants (6-17 Years of Age) With Episodic Migraine
Episodic Migraine
AbbVie450 enrolled98 locationsNCT05711394
Recruiting
Phase 3
Study to Assess Adverse Events and Disease Activity of Oral Ubrogepant Tablets for the Acute Treatment of Migraine in Children and Adolescents (Ages 6-17)
Migraine
AbbVie1,059 enrolled124 locationsNCT05125302
Recruiting
Observational Study of Oral Atogepant to Evaluate Real-World Effectiveness in Adult Participants With Migraine
Migraine
AbbVie1,000 enrolled111 locationsNCT06543914
Recruiting
Phase 2
A Study to Investigate the Safety and Efficacy of MEDI0618 Compared to Placebo in Adult Participants With Episodic Migraine
Migraine
AbbVie488 enrolled54 locationsNCT06602479
Recruiting
Not Applicable
A PIVOTAL STUDY EVALUATING SAFETY AND EFFICACY OF THE SHIRATRONICS MIGRAINE THERAPY SYSTEM
Headache Migraine Chronic
ShiraTronics250 enrolled23 locationsNCT06167655
Recruiting
Phase 3
Study of Oral Ubrogepant to Assess Adverse Events and Change in Disease Activity in Adult Participants With Menstrual Migraine
Migraine
AbbVie496 enrolled106 locationsNCT06417775
Recruiting
Not Applicable
RELAXaHEAD for Headache Patients (Phase III)
Migraine
NYU Langone Health356 enrolled1 locationNCT06077838
Recruiting
Phase 4
Acute Migraine Treatment in the ED With Gepants
Migraine Headaches
Icahn School of Medicine at Mount Sinai100 enrolled1 locationNCT06985342